Last $2.60 USD
Change Today +0.04 / 1.56%
Volume 911.8K
RIGL On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James M. Gower

Chairman, Chief Executive Officer and Member of Finance Committee, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 2 different industries.

See Board Relationships
65$1,709,874
As of Fiscal Year 2013

Background*

Mr. James M. Gower has been the Chief Executive Officer of Rigel Pharmaceuticals, Inc. since January 1997 and has been its Chairman since October 2001. Mr. Gower serves as an Advisor of VantagePoint Venture Partners. He served as President at Rigel Pharmaceuticals, Inc., since January 1997. From 1992 to March 1996, he served as the President and Chief Executive Officer of Tularik, Inc. He held several positions with Genentech, Inc., as Senior Vice President, responsible ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

1996-N/A
Former Director
1997-Present
Chairman, Chief Executive Officer and Member of Finance Committee

Education*

BS
University of Tennessee System, The
MBA
University of Tennessee System, The

Other Affiliations*

Annual Compensation*

Salary$695,118
Total Annual Compensation$695,118

Stock Options*

All Other Compensation$9,906
Exercisable Options1,423,125
Unexercisable Options121,875
Total Number of Options1,545,000

Total Compensation*

Total Annual Cash Compensation$705,024
Total Short Term Compensation$695,118
Other Long Term Compensation$9,906
Total Calculated Compensation$1,709,874
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $2.60 USD +0.04

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.